(+)-AffinisineCAS# 2912-11-0 |
Package In Stock
Quality Control & MSDS
Chemical structure
3D structure
Number of papers citing our products
Cas No. | 2912-11-0 | SDF | Download SDF |
PubChem ID | 5281346 | Appearance | Powder |
Formula | C20H24N2O | M.Wt | 308.4 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CC=C1CN2C3CC1C(C2CC4=C3N(C5=CC=CC=C45)C)CO | ||
Standard InChIKey | UVWQYWHKTZABSO-MXSXYYJRSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
(+)-Affinisine Dilution Calculator
(+)-Affinisine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.2425 mL | 16.2127 mL | 32.4254 mL | 64.8508 mL | 81.0636 mL |
5 mM | 0.6485 mL | 3.2425 mL | 6.4851 mL | 12.9702 mL | 16.2127 mL |
10 mM | 0.3243 mL | 1.6213 mL | 3.2425 mL | 6.4851 mL | 8.1064 mL |
50 mM | 0.0649 mL | 0.3243 mL | 0.6485 mL | 1.297 mL | 1.6213 mL |
100 mM | 0.0324 mL | 0.1621 mL | 0.3243 mL | 0.6485 mL | 0.8106 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Guanfacine hydrochloride
Catalog No.:BCC1609
CAS No.:29110-48-3
- Guanfacine
Catalog No.:BCC5180
CAS No.:29110-47-2
- Procyanidin B2
Catalog No.:BCN6315
CAS No.:29106-49-8
- Pinoresinol dimethyl ether
Catalog No.:BCN6767
CAS No.:29106-36-3
- Glipizide
Catalog No.:BCC3785
CAS No.:29094-61-9
- Cimiracemoside D
Catalog No.:BCN2789
CAS No.:290821-39-5
- Avosentan
Catalog No.:BCC1387
CAS No.:290815-26-8
- Eupteleasaponin I
Catalog No.:BCN7839
CAS No.:290809-29-9
- 5-Hydroxy-3',4',7-trimethoxyflavone
Catalog No.:BCN5194
CAS No.:29080-58-8
- Pachymic acid
Catalog No.:BCN6347
CAS No.:29070-92-6
- Hexanorcucurbitacin D
Catalog No.:BCN7875
CAS No.:29065-05-2
- Matricin
Catalog No.:BCC8209
CAS No.:29041-35-8
- 1-Methoxyberberine
Catalog No.:BCN7373
CAS No.:29133-52-6
- [Ala11,22,28]VIP
Catalog No.:BCC5754
CAS No.:291524-04-4
- Shegansu B
Catalog No.:BCN3381
CAS No.:291535-65-4
- 3',6'-Bis(diethylamino)-2-(4-nitrophenyl)spiro[isoindole-1,9'-xanthene]-3-one
Catalog No.:BCC8597
CAS No.:29199-09-5
- Methylprednisolone hemisuccinate
Catalog No.:BCC9044
CAS No.:2921-57-5
- Adenine HCl
Catalog No.:BCC4453
CAS No.:2922-28-3
- H-DL-Phe(4-NO2)-OH
Catalog No.:BCC3279
CAS No.:2922-40-9
- L-Kynurenine
Catalog No.:BCC3899
CAS No.:2922-83-0
- Dehydrotrametenolic acid
Catalog No.:BCN2718
CAS No.:29220-16-4
- SB-3CT
Catalog No.:BCC5486
CAS No.:292605-14-2
- 25,26-Dihydroxyvitamin D3
Catalog No.:BCC4201
CAS No.:29261-12-9
- L-685,458
Catalog No.:BCC2344
CAS No.:292632-98-5
Concise Total Synthesis of (-)-Affinisine Oxindole, (+)-Isoalstonisine, (+)-Alstofoline, (-)-Macrogentine, (+)-Na -Demethylalstonisine, (-)-Alstonoxine A, and (+)-Alstonisine.[Pubmed:28875520]
Chemistry. 2017 Nov 7;23(62):15805-15819.
A highly enantio- and diastereoselective strategy to access any member of the sarpagine/macroline family of oxindole alkaloids via internal asymmetric induction was developed from readily available d-(+)-tryptophan. At the center of this approach was the diastereospecific generation of the spiro[pyrrolidine-3,3'-oxindole] moiety at an early stage via a tert-butyl hypochlorite-promoted oxidative rearrangement of a chiral tetrahydro-beta-carboline derivative. This key branching point determined the spatial configuration at the C-7 spiro center to be entirely 7R or 7S. Other key stereospecific processes were the asymmetric Pictet-Spengler reaction and Dieckmann cyclization, which were scalable to the 600 and 150 gram levels, respectively. Execution of this approach resulted in first enantiospecific total synthesis of (+)-isoalstonisine and (-)-macrogentine from the chitosenine series (7R), as well as (+)-alstonisine, (+)-alstofoline, (-)-alstonoxine A and (+)-Na -demethylalstonisine from the alstonisine series (7S).